Literature DB >> 3007480

Muscarinic receptor enhancement of nicotine-induced catecholamine secretion may be mediated by phosphoinositide metabolism in bovine adrenal chromaffin cells.

E J Forsberg, E Rojas, H B Pollard.   

Abstract

Bovine adrenal chromaffin cells possess both nicotinic and muscarinic cholinergic receptors, but only nicotinic receptors have heretofore appeared to mediate Ca2+-dependent exocytosis. We have now found that muscarinic receptor stimulation in bovine adrenal chromaffin cells leads to enhanced inositol phospholipid metabolism as evidenced by the rapid (less than 1 min) formation of inositol trisphosphate (IP3) and inositol bisphosphate (IP2). Muscarinic receptor-mediated accumulation of IP3 and IP2 continues beyond 1 min in the presence of LiCl and is accompanied by large increases in inositol monophosphate. Muscarinic receptor stimulation was also found to enhance nicotine-induced catecholamine secretion by 1.7-fold if muscarine was added 30 s before nicotine addition. Moreover, since the muscarinic antagonist atropine reduces acetylcholine-induced secretion, we conclude that muscarinic receptor stimulation somehow primes these cells for nicotinic receptor-mediated secretion, perhaps by causing small nonstimulatory increases in cytosolic free Ca2+ mediated by IP3. Furthermore, we show that small depolarizations of these cells with 10 mM K+, which themselves do not affect basal secretion, also enhance nicotine-induced secretion. Thus, small increases in cytosolic free Ca2+ produced either by physiologic muscarinic receptor stimulation or by small experimental depolarizations with K+ may prime the chromaffin cells for nicotinic receptor-mediated secretion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007480

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Muscarinic receptor subtypes in bovine adrenal medulla.

Authors:  J S Aguilar; J J Ballesta; J A Reig; M Palmero; S Viniegra; M Criado
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

2.  Opioid enhancement of evoked [Met5]enkephalin release requires activation of cholinergic receptors: possible involvement of intracellular calcium.

Authors:  H Xu; A R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

3.  Functional shift from muscarinic to nicotinic cholinergic receptors involved in inositol trisphosphate and cyclic GMP accumulation during the primary culture of adrenal chromaffin cells.

Authors:  T Nakaki; N Sasakawa; S Yamamoto; R Kato
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

4.  Proceedings of the British Pharmacological Society. 6th-8th January, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

5.  Effects of calcium and Bay K-8644 on calcium currents in adrenal medullary chromaffin cells.

Authors:  V Ceña; A Stutzin; E Rojas
Journal:  J Membr Biol       Date:  1989-12       Impact factor: 1.843

6.  Mixed nicotinic and muscarinic features of cholinergic receptor coupled to secretion in bovine chromaffin cells.

Authors:  M H Shirvan; H B Pollard; E Heldman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  Strychnine affects catecholamine secretion from bovine adrenal medulla chromaffin cells.

Authors:  D E Dar; O Zinder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

8.  Secretory and radioligand binding studies on muscarinic receptors in bovine and feline chromaffin cells.

Authors:  J J Ballesta; R Borges; A G García; M J Hidalgo
Journal:  J Physiol       Date:  1989-11       Impact factor: 5.182

9.  Cholinoceptor regulation of cyclic AMP levels in bovine adrenal medullary cells.

Authors:  K Anderson; P J Robinson; P D Marley
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

10.  Endocrine responses to intra-aortic infusions of acetylcholine in conscious calves.

Authors:  C T Jones; A V Edwards; S R Bloom
Journal:  J Physiol       Date:  1991-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.